East Midlands Spine Ltd
Northampton, United Kingdom
NCT Number: NCT04418362
A mixed methods proof of concept study to ascertain the effectiveness of a home-based self-administered neurofeedback intervention to treat the primary and secondary symptoms of chronic pain.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Northampton, United Kingdom
In order to address the growing problem of chronic pain management in the UK, a proof of concept/feasibility open label study has been devised to test a home-based self-administered non-pharmacological treatment utilising neurofeedback training with a headset and tablet-based software application.
This study will include individuals suffering from various types of chronic pain, measuring changes in pain intensity alongside associated symptoms (depression, anxiety, sleep, and quality of life) by utilising a purpose-built software application and headset that is easy to use and structurally robust.
Twenty participants will take part in pre-intervention quantitative assessments measuring the primary and secondary symptoms of chronic pain. This will be followed by one-to-one remote training where they will be provided with detailed instructions on how to self-administer the neurofeedback training in the comfort of their own homes. They will then take part in 4-6 training sessions per week over an 8-week period.
Post- intervention quantitative assessments will be conducted alongside a qualitative analysis of the experience of doing neurofeedback training for chronic pain. Participant feedback on how the protocol, equipment and research could be improved will also be recorded to inform further research.
Participants will also take part in online follow-up assessments at 1, 3, and 6 months after the intervention. Any adjustments to pain medication will also be recorded over this period. It is anticipated this study will provide initial evidence of the safety, efficacy, reliability and validity of a low-cost non-pharmacological solution to the physical, psychological and social difficulties experienced by individuals with chronic pain, with a view to a larger subsequent multisite trial.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A home-based self-administered neurofeedback intervention taking place 4-6 times per week for 8 weeks.
Time frame: Pre-intervention, before and after each training session over 8 week period, and 1, 3 and 6 months after final training session
Ordinal measurement of individual's pain intensity
Time frame: Pre-intervention, after the final training session (8 weeks), and 1, 3 and 6 months after final session
Rating scale (self-administered)
Time frame: Pre-intervention, after the final training session (8 weeks), and 1, 3 and 6 months after final session
A self-report questionnaire assessing sleep quality
Time frame: Pre-intervention, after the final training session (8 weeks), and 1, 3 and 6 months after final session
A self-assessed, health related, quality of life questionnaire.
Time frame: Baseline (eyes open and eyes closed) pre-intervention, and before and after each training session over 8 weeks
Changes in relative Alpha, Theta and Beta ratio, as measured by EEG
Time frame: Post-intervention - after final training session (8 weeks)
Qualitative interviews of the lived experience of taking part in neurofeedback training for chronic pain
Exsurgo Rehab Limited
Industry
Axon - Brain Train for Pain - A Home-based Neurofeedback Intervention to Treat the Primary and Secondary Symptoms of Chronic Pain
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06353100
Anxiety Disorders, Behavior
Santiago, RM, Chile
View Trial DetailsNCT06545513
Anxiety Disorders, Behavior
Amsterdam, North Holland, Netherlands
View Trial DetailsNCT04419168
Anemia, Anemia, Hemolytic
Chicago, Illinois, United States
View Trial DetailsNCT03296007
Anxiety Disorders, Behavior
Toronto, Ontario, Canada
View Trial Details